The CEO of Turing Pharmaceuticals is defending his decision to raise the price of the life-saving drug Daraprim from $13.50 to $750 a tablet. Outrage over his decision has spread to the campaign trial and triggered instability on Wall Street. New York Times Reporter Andrew Pollack and Infectious Disease Specialist, Dr. Frank Esper join NewsNation.Sept. 22, 2015
UP NEXT
Rep. Raskin says Trump 'had violence within his sights’ on Jan. 6
03:31
Cassidy Hutchinson: Giuliani, Meadows suggested interest in presidential pardon related to Jan. 6
01:36
Battle over reproductive rights could impact Georgia AG race
06:43
The Last Thing: Rudy Slaps Back
03:16
Footage of Rudy Giuliani encounter reveals what actually went down
03:04
Blue states will begin to see 'reproductive refugees' because of ruling, says professor